Katie Streicher

Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial

Christopher E. Brightling, Pascal Chanez, Richard Leigh et al. · The Lancet Respiratory Medicine · 2015 · 363 citations

Asthma, Rheumatology, Allergy +7

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer

Liyan Jiang, Jiaqi Huang, Brandon W. Higgs et al. · PLoS Genetics · 2016 · 265 citations · Full text

Engineering, Pathology, Key Oncodriver +17

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

Hugh Montgomery, Richard Hobbs, Francisco Padilla et al. · The Lancet Respiratory Medicine · 2022 · 223 citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Placebo-controlled Trial +4

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans

Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends et al. · Science Translational Medicine · 2022 · 208 citations · Full text

Humoral Response, Immunology, Viral Pathogenesis +18

Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab

Brandon W. Higgs, Christopher Morehouse, Katie Streicher et al. · Clinical Cancer Research · 2018 · 205 citations · Full text